SEC Tracker
Get the app

Pfizer PFE

Phantom stock units acquired: 20

Albert Bourla, insider filing for PFE

Form
4
Filed
Importance
Routine
  1. Phantom stock units acquired: 20
  2. Settled in cash after separation
  3. Under deferred compensation plan

Written from the Form 4 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Pfizer files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Amgen AMGN public float $150.1B, Jun 30, 2025
  2. Vertex Pharmaceuticals VRTX public float $113.4B, Jun 30, 2025
  3. Gilead Sciences GILD public float $103.2B, Jun 30, 2025
  4. Merck MRK public float $198.1B, Jun 30, 2025
  5. Bristol Myers Squibb BMY public float $94.2B, Jun 30, 2025